Thomas J. Schall, President and CEO at ChemoCentryx, Inc. (CCXI), sold 157,333 shares at $50.41 ($7.9M) on 2020-02-19, disclosed to the SEC on 2020-02-21.
Open-market sale of $7.9M CCXI by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.41 | 55,617 | $2.8M | 35.3% |
| 2 | $50.41 | 55,617 | $2.8M | 35.3% |
| 3 | $51.14 | 7,723 | $395K | 5.0% |
| 4 | $51.14 | 7,723 | $395K | 5.0% |
| 5 | $50.21 | 15,312 | $769K | 9.7% |
| 6 | $50.21 | 15,312 |
| $769K |
| 9.7% |
| 7 | $51.10 | 29 | $1K | 0.0% |
| Total | $50.44 avg | 157,333 | $7.9M | 100% |
| Filing → |
| IMRX | BUY | 2025-06-18 | $179K | — | Filing → |
| IMRX | BUY | 2024-03-25 | $7K | — | Filing → |
| CCXI | SELL | 2022-08-08 | $6.5M | — | Filing → |